John Saharek
Corporate Officer/Principal bei HARROW, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
John P.
Saharek is currently the President & Chief Executive Officer at ImprimisRx LLC since 2012 and the Chief Commercial Officer at Harrow, Inc. since 2012.
Previously, he worked as the Vice President-Business Development at Surmodics, Inc. from 2006 to 2011.
He also held the position of Head-US Marketing & Strategy at Thrombogenics, Inc. Mr. Saharek completed his undergraduate degree at Central Connecticut State University and obtained an MBA from the University of Hartford.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HARROW, INC.
0,71% | 16.04.2024 | 249 803 ( 0,71% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von John Saharek
| Unternehmen | Position | Beginn |
|---|---|---|
| HARROW, INC. | Corporate Officer/Principal | 01.02.2015 |
| ImprimisRx LLC | Vorstandsvorsitzender | 02.01.2024 |
Ehemalige bekannte Positionen von John Saharek
| Unternehmen | Position | Ende |
|---|---|---|
| SURMODICS, INC. | Corporate Officer/Principal | 01.07.2011 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Vertrieb & Marketing | - |
Ausbildung von John Saharek
| University of Hartford | Masters Business Admin |
| Central Connecticut State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HARROW, INC. | Health Technology |
| SURMODICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
| ImprimisRx LLC |
